Katrina M. Lappin

Belfast, NIR, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Current perspectives on KMT2A fusion proteins and menin inhibition in paediatric acute myeloid leukaemia.

Current perspectives on KMT2A fusion proteins and menin inhibition in paediatric acute myeloid leukaemia.

Journal: The FEBS journal
Published: May 26, 2025

Platelet Pathogen Reduction Technology-Should We Stay or Should We Go…?

Platelet Pathogen Reduction Technology-Should We Stay or Should We Go…?

Journal: Journal of clinical medicine
Published: July 18, 2024

The cancer-associated SF3B1K700E spliceosome mutation confers enhanced sensitivity to BV-6-induced cytotoxicity.

The cancer-associated SF3B1K700E spliceosome mutation confers enhanced sensitivity to BV-6-induced cytotoxicity.

Journal: Cell death & disease
Published: March 11, 2024

Combination Therapies Targeting Apoptosis in Paediatric AML: Understanding the Molecular Mechanisms of AML Treatments Using Phosphoproteomics.

Combination Therapies Targeting Apoptosis in Paediatric AML: Understanding the Molecular Mechanisms of AML Treatments Using Phosphoproteomics.

Journal: International journal of molecular sciences
Published: January 26, 2023

Multiplex Screening for Interacting Compounds in Paediatric Acute Myeloid Leukaemia.

Multiplex Screening for Interacting Compounds in Paediatric Acute Myeloid Leukaemia.

Journal: International journal of molecular sciences
Published: July 26, 2021

Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors.

Cancer-Associated SF3B1 Mutations Confer a BRCA-Like Cellular Phenotype and Synthetic Lethality to PARP Inhibitors.

Journal: Cancer research
Published: June 08, 2021

Erythropoietin in bone homeostasis-Implications for efficacious anemia therapy.

Erythropoietin in bone homeostasis-Implications for efficacious anemia therapy.

Journal: Stem cells translational medicine
Published: August 18, 2020

A compound combination screening approach with potential to identify new treatment options for paediatric acute myeloid leukaemia.

A compound combination screening approach with potential to identify new treatment options for paediatric acute myeloid leukaemia.

Journal: Scientific reports
Published: June 02, 2020

Chronic loss of STAG2 leads to altered chromatin structure contributing to de-regulated transcription in AML.

Chronic loss of STAG2 leads to altered chromatin structure contributing to de-regulated transcription in AML.

Journal: Journal of translational medicine
Published: May 26, 2020

Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability.

Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability.

Journal: Scientific reports
Published: September 20, 2018

Polycomb protein RING1A limits hematopoietic differentiation in myelodysplastic syndromes.

Polycomb protein RING1A limits hematopoietic differentiation in myelodysplastic syndromes.

Journal: Oncotarget
Published: April 04, 2017

Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapy.

Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapy.

Journal: Oncotarget
Published: October 15, 2016
Showing 1-12 of 12

Last Updated: 09/26/2026